Newsblog

Dr. Mario Iannaccone is interviewed on "Comparison of ECMO vs ECpella in patients with non post-pericardiotomy cardiogenic shock: An updated meta-analysis".

Based on publication of the same name in Cardiovascular Revascularization Medicine (2021)

Navin Kapur, MD, discusses clinical evidence for what he calls “on-pump” complex PCI, especially related to patients with heart failure. Dr.

Dr. Mario Iannaccone is interviewed on "Short term outcomes of Impella® circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis"

Prof. Dr. Andreas Schäfer is interviewed on Complete Revascularization in Impella® Supported Infarct Related CGS Patients is Associated with Improved Mortality.

Dr. Mario Iannaccone is interviewed on "Short term outcomes of Impella® in cardiogenic shock: A review and meta-analysis of observational studies".

Based on publication in International Journal of Cardiology (2020)

Prof. Böning from Gießen (Germany) presented the creation of a European MCS registry including Impella and ECLS patients.

PD Schmack (Essen, Germany) explained that Impella can also give support in other indications than CS, e.g. in structural heart disease of mitral regurgitation, due to the overestimation of LV function.

Prof. Potapov from Berlin (Germany) highlighted the upgrade of the ESC guidelines of temporary MCS from IIb to IIa, whereas IABP is not recommended any more.

Dr. Bernhardt from Hamburg (Germany) demonstrated the usefulness of Impella® 5.0 and 5.5 pumps for bridge to decision making (BTD) in patients with unclear neurological prognosis.

Prof. Reichenspurner from Hamburg (Germany) presented the study design of the initial pilot trial of the IMpella Protected cArdiac surgery Trial (IMPACT).

Dr. Oezkur (Mainz, Germany) presented the PRotected off-pump coronary artery bypass grafting with IMpElla (PRIME) study series to improve outcome in OPCAB surgery.

William O'Neill, MD, diskutiert die Protected PCI als praktischen Ansatz zur mechanischen Kreislaufunterstützung bei elektiven komplexen PCI-Fällen.

Jeffrey Moses, MD, erörtert die verbesserten Ergebnisse, die in der PROTECT-III-Studie mit Impella Herzpumpen gestützten Hochrisiko-PCI-Patienten erzielt wurden.

Jason Wollmuth, MD, diskutiert Best Practises für die Behandlung von Hochrisiko-PCI-Patienten über den Large-Bore-Zugang und die intravaskuläre Bildgebung.

In seinem Vortrag erläutert Prof. Dr. Carsten Tschöpe die Klassifikation der Society for Cardiovascular Angiography & Interventions (SCAI) zur Beurteilung von Patienten im kardiogenen Schock.